WASHINGTON (AP) - Federal health regulators have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial.
The Food and Drug Administration said Tuesday it is still gathering information about the death, but has shut down all studies of the drug in children.
Sensipar is approved in adults to treat over-activity of the parathyroid gland. It has been used since 2004 to treat symptoms of chronic kidney disease and parathyroid cancer.
Amgen Inc. had been studying the drug to see whether it works in children.
The Thousand Oaks, Calif.-based company said in a statement that it "is working as rapidly as possible to understand the circumstances of what happened."
The FDA said on its website that it is unclear whether Amgen's drug had a role in the patient's death, but it is reminding doctors to prescribe it carefully.
The drug is known to lower calcium levels, sometimes to a dangerous extent.
The agency says doctors should monitor patients' calcium levels monthly to make sure they don't fall to dangerous levels. Signs of a calcium deficiency include muscle cramping, convulsions and burning or prickling sensations.
The most common side effects of the drug in adults include nausea, vomiting and diarrhea.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
If the fee was enacted as planned in the New Starts application, the expected $555 million in revenue would almost double the amount of taxes and fees motorists currently pay to the state through gas taxes
Ronald Nored, guard for the Butler University basketball teams that went to back-to-back Final Fours in the NCAA Tournament, has already landed his first coaching gig. The former Bulldog will lead the Brownsburg High School Bulldogs.
The university announced Blue III, also known as Trip, on Thursday. He was born Dec. 23 in Indiana. The university's current live mascot, Blue II, remains with the school.